Golden
Scaled Biolabs

Scaled Biolabs

Scaled Biolabs has developed a platform based on microfluidic technology that allows researchers to perform thousands of simultaneous cell culture experiments.

All edits by  Carla Faraguna 

Edits on 12 Feb 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 12 Feb 2019 6:47 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 1 Oct 2018
Carla Faraguna
Carla Faraguna edited on 1 Oct 2018 6:00 pm
Edits made to:
Infobox (+1 properties)
Edits on 28 Sep 2018
Carla Faraguna
Carla Faraguna edited on 28 Sep 2018 10:09 pm
Edits made to:
Infobox (+1 properties)
Description (+159 characters)
Article (+681 characters)
People (+5 characters)
Categories (+2 topics)
Topic thumbnail

Scaled Biolabs

Scaled Biolabs has developed a platform based on microfluidic technology that allows researchers to perform thousands of simultaneous cell culture experiments.

Article

Scaled Biolabs has developed a new platform based on microfluidic technology spun-out of The University of Queensland's Australian Institute for Bioengineering and Nanotechnology that allows researchers to perform thousands of simultaneous cell culture experiments.

...

Scaled Biolabs is developing a Cell Therapy Discovery Engine to create cell-based medicines. This engine allows biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson's disease.

People

Name
Role
Related Golden topics

Drew Titmarsh

Founder, CEO



Infobox

Categories

Edits on 30 May 2018
Carla Faraguna
Carla Faraguna edited on 30 May 2018 10:00 pm
Edits made to:
Related Topics (+1 topics)

Related Topics

Carla Faraguna"Initial topic creation"
Carla Faraguna created this topic on 30 May 2018 10:00 pm
Edits made to:
Topic thumbnail

 Scaled Biolabs

Scaled Biolabs has developed a platform based on microfluidic technology that allows researchers to perform thousands of simultaneous cell culture experiments.

No more activity to show.